XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands, € in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Cash flows from operating activities:      
Net income $ 143,313 $ 987,864 $ 605,100
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization of property and equipment 399,486 396,342 357,529
Amortization of acquired intangibles 1,262,969 1,295,042 1,256,911
Amortization of capitalized contract costs 109,701 93,328 78,147
Share-based compensation expense 163,261 180,779 148,792
Provision for operating losses and bad debts 116,879 90,208 126,712
Noncash lease expense 78,935 107,775 98,592
Deferred income taxes (315,495) (189,050) (166,224)
Equity in income of equity method investments, net of tax (85,685) (112,353) (88,297)
Facilities exit charges 30,437 51,349 0
Distributions received on investments 45,521 36,914 7,738
Impairment of goodwill 833,075 0 0
Loss on business dispositions 199,094 0 0
Other, net 993 10,810 (21,403)
Changes in operating assets and liabilities, net of the effects of business combinations:      
Accounts receivable (111,974) (165,543) 55,986
Settlement processing assets and obligations, net (313,333) 128,584 125,852
Prepaid expenses and other assets (295,980) (264,009) (270,965)
Accounts payable and other liabilities (17,157) 132,785 (320)
Net cash provided by operating activities 2,244,040 2,780,825 2,314,150
Cash flows from investing activities:      
Business combinations and other acquisitions, net of cash acquired (65,672) (1,811,432) (160,801)
Restricted cash from business combinations 0 0 119,372
Capital expenditures (615,652) (493,216) (436,236)
Effect on cash from sale of business (29,755) 0 0
Proceeds from sale of investments 33,046 0 0
Other, net 2,496 10,822 39,323
Net cash used in investing activities (675,537) (2,293,826) (438,342)
Cash flows from financing activities:      
Net borrowings from (repayments of) settlement lines of credit 285,644 149,528 (133,282)
Proceeds from long-term debt 9,812,289 7,057,668 2,401,147
Repayments of long-term debt (7,895,131) (4,826,769) (2,342,072)
Payments of debt issuance costs (48,635) (21,320) (8,075)
Repurchases of common stock (2,921,307) (2,533,629) (631,148)
Proceeds from stock issued under share-based compensation plans 44,127 49,545 66,142
Common stock repurchased - share-based compensation plans (38,601) (90,649) (61,243)
Distributions to noncontrolling interests (23,031) 0 (26,199)
Contributions from noncontrolling interests 0 69,987 0
Payment of contingent consideration in business combination (15,726) 0 0
Purchase of capped calls related to issuance of convertible notes (302,375) 0 0
Dividends paid (273,955) (259,726) (233,216)
Purchase of subsidiary shares from noncontrolling interest 0 0 (578,196)
Net cash used in financing activities (1,376,701) (405,365) (1,546,142)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (99,219) (48,382) 81,832
Increase in cash, cash equivalents and restricted cash 92,583 33,252 411,498
Cash, cash equivalents and restricted cash, beginning of the period 2,123,023 2,089,771 1,678,273
Cash, cash equivalents and restricted cash, end of the period $ 2,215,606 $ 2,123,023 $ 2,089,771